Apures Co., Ltd. (XKON:149300)

Market Cap	5.82B
Revenue (ttm)	517.33M
Net Income (ttm)	-3.73B
Shares Out	45.49M
EPS (ttm)	-138.55
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	97,250
Average Volume	30,729
Open	143.00
Previous Close	133.00
Day's Range	114.00 - 143.00
52-Week Range	41.00 - 487.00
Beta	-0.44
RSI	40.60
Earnings Date	n/a

About Apures

Apures Co., Ltd. engages in the development and commercialization of solutions for the bio and medical industries in South Korea. It is involved in the development of MICROPIG, which are research and laboratory mini pig species to provide solutions through standardization of biomaterials for medical experiments and development of regenerative medicine treatments, including cell therapy and heterogeneous organs. The company provides Porcine Primary Cell for in vitro test; and heterogeneous organ technology, a technology that develops and transpl...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 149300

Financial Performance

In 2018, Apures's revenue was 528.64 million, an increase of 28.45% compared to the previous year's 411.56 million. Losses were -4.68 billion, -16.82% less than in 2017.